Revolution Medicines Inc. (RVMD): Price and Financial Metrics
RVMD Price/Volume Stats
| Current price | $35.83 | 52-week high | $38.73 |
| Prev. close | $36.82 | 52-week low | $15.44 |
| Day low | $35.79 | Volume | 1,059,300 |
| Day high | $37.19 | Avg. volume | 1,388,779 |
| 50-day MA | $31.59 | Dividend yield | N/A |
| 200-day MA | $28.19 | Market Cap | 5.90B |
RVMD Stock Price Chart Interactive Chart >
Revolution Medicines Inc. (RVMD) Company Bio
Revolution Medicines, Inc. is a clinical-stage precision oncology company focused on developing novel targeted therapies. It engages in the discovery and development of cancer treatment by pioneering novel combination and monotherapy treatment regimens to maximize the depth and durability of clinical benefit and circumvent adaptive resistance mechanisms for patients which are dependent on the RAS and mTOR pathway. The company was founded by Mark A. Goldsmith, Kevan Shokat, Martin D. Burke, David L. Pompliano and Michael Fischbach in October 2014 and is headquartered in Redwood City, CA.
Latest RVMD News From Around the Web
Below are the latest news stories about REVOLUTION MEDICINES INC that investors may wish to consider to help them evaluate RVMD as an investment opportunity.
Revolution Medicines Inc Insider Sells SharesMargaret Horn, COO of Revolution Medicines Inc (NASDAQ:RVMD), sold 7,993 shares of the company on December 18, 2023, according to a recent SEC Filing. |
Pharma’s Frontline: 3 Stocks Driving Revolutionary Drug DevelopmentThese pharma stock leaders offer revolutionary treatments that could change the world of medicine (and investor's portfolios) for the better. |
Insider Sell Alert: COO Margaret Horn Sells 5,000 Shares of Revolution Medicines Inc (RVMD)In the realm of biopharmaceuticals, insider transactions are often scrutinized for insights into the company's health and future prospects. |
A great week that adds to Revolution Medicines, Inc.'s (NASDAQ:RVMD) one-year returns, institutional investors who own 74% must be happyKey Insights Given the large stake in the stock by institutions, Revolution Medicines' stock price might be vulnerable... |
3 Biotech Stocks That Could Boom or Bust by 2025Biotech stocks are popular with investors because they sometimes provide tremendous rewards. |
RVMD Price Returns
| 1-mo | 16.33% |
| 3-mo | 33.05% |
| 6-mo | 28.10% |
| 1-year | 42.30% |
| 3-year | -8.95% |
| 5-year | N/A |
| YTD | 24.93% |
| 2023 | 20.40% |
| 2022 | -5.36% |
| 2021 | -36.42% |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...